Insurers lean toward generic alternatives














Insurers have traditionally focused their attention on savings through therapeutic equivalents, which contain the same active ingredients, strength, and dosage form as the original brand-name drug. But, according to an article published in the British Journal of Generic Medicines titled “Maximising Generic Utilization: The Power of Pharmacy Benefit Management,” more insurers are focusing their attention on a second approach to generic drug management — generic alternatives, which contain different active ingredients, but have comparable efficacy to brand-name drugs in the same class. For example, some plans may encourage the use of generic omeprazole as a therapeutic alternative to patent-protected brands in the proton pump inhibitor class.

In 2006, brand-name drugs accounted for about 42 percent of total dispensing volume, according to Medco Health Solutions. About 9 percent of the current dispensing volume could be converted to therapeutic equivalents over the next three years. An additional 11 percent to 16 percent of current dispensing could be converted to generics because new generics expand the range of treatment options. High-priced brands are the best candidates to switch because the large cost differentials are an incentive for payers and members to change therapy.

Source: Snow, DB. 2007. J Generic Medicines. 5:27–38.

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to jfedder1@hfhs.org or online at http://p.rfer.us/HENRYFORDlXqAJA

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.

UP NEXT

Managed Care
By Peter Wehrwein
Managed Care
By Howard Wolinsky